Sankei Chemical Income Statement

Financials in millions JPY. Fiscal year is December - November.

Millions JPY. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Revenue	6,444	6,052	5,998	7,242	7,032
Revenue Growth (YoY)	6.48%	0.90%	-17.18%	2.99%	4.78%
Cost of Revenue	4,839	4,684	4,665	5,672	5,212
Gross Profit	1,605	1,368	1,333	1,570	1,820
Selling, General & Admin	1,424	1,099	1,111	1,119	1,131
Research & Development	-	224	233	218	183
Other Operating Expenses	-	-	-	-	113
Operating Expenses	1,424	1,323	1,344	1,337	1,427
Operating Income	181	45	-11	233	393
Interest Expense	-24	-21	-17	-14	-13
Interest & Investment Income	12	16	14	13	9
Earnings From Equity Investments	87	66	30	31	40
Other Non Operating Income (Expenses)	23	31	21	37	23
EBT Excluding Unusual Items	279	137	37	300	452
Gain (Loss) on Sale of Investments	-	16	16	-	-
Gain (Loss) on Sale of Assets	1	64	-	-	-
Asset Writedown	-1	-	-1	-2	-9
Other Unusual Items	-66	-	1	-	-
Pretax Income	213	217	53	298	443
Income Tax Expense	29	51	10	80	120
Earnings From Continuing Operations	184	166	43	218	323
Minority Interest in Earnings	-3	-34	-7	-6	-10
Net Income	181	132	36	212	313
Net Income to Common	181	132	36	212	313
Net Income Growth	37.12%	266.67%	-83.02%	-32.27%	114.38%
Shares Outstanding (Basic)	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1
Shares Change (YoY)	-1.24%	-4.00%	-1.35%	-0.02%	-0.02%
EPS (Basic)	201.95	145.44	38.08	221.23	326.57
EPS (Diluted)	201.95	145.44	38.08	221.23	326.57
EPS Growth	38.85%	281.95%	-82.79%	-32.26%	114.42%
Free Cash Flow	357	387	-462	-270	521
Free Cash Flow Per Share	398.32	426.42	-488.69	-281.76	543.59
Dividend Per Share	30.000	25.000	25.000	30.000	25.000
Dividend Growth	20.00%	-	-16.67%	20.00%	31.58%
Gross Margin	24.91%	22.60%	22.22%	21.68%	25.88%
Operating Margin	2.81%	0.74%	-0.18%	3.22%	5.59%
Profit Margin	2.81%	2.18%	0.60%	2.93%	4.45%
Free Cash Flow Margin	5.54%	6.40%	-7.70%	-3.73%	7.41%
EBITDA	315	171	107	336	500
EBITDA Margin	4.89%	2.83%	1.78%	4.64%	7.11%
D&A For EBITDA	134	126	118	103	107
EBIT	181	45	-11	233	393
EBIT Margin	2.81%	0.74%	-0.18%	3.22%	5.59%
Effective Tax Rate	13.61%	23.50%	18.87%	26.85%	27.09%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.